Spanish Drugmakers Fleeing Crisis Follow Almirall’s Path

As Spain’s economy was booming more than a decade ago, drugmaker Almirall SA decided it was time to boost international sales, treading a path that other companies are now following to offset health cuts in the debt-ravaged country.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.